台股 » 個股 » 愛普* » 個股(權證)/期貨 » 個股權證

愛普*

(6531)
可現股當沖
  • 股價
    396.5
  • 漲跌
    ▲0.5
  • 漲幅
    +0.13%
  • 成交量
    1,800
  • 產業
    上市 半導體類股
  • 615人加入追蹤

    立即追蹤

  • 本地時間:14:30

     

愛普* (6531) 個股權證

愛普* (6531) 個股權證-認購
權證代號價格漲跌漲跌幅買價賣價成交量成交
波動
買價
波動
賣價
波動
買賣
價差
履約價行使
比例
價內外程度實質
槓桿
剩餘
天數
愛普元大51購01 086329 1.63 ▲0.08 +5.16% 1.471.52690.00%72.04%74.20%0.02%3750.035 價內 -5.733% 0 28
愛普兆豐52購01 086337 1.92 ▲0.11 +6.08% 1.761.7800.00%0.00%0.00%0.01%388.880.04 價平 -1.959% 0 60
愛普元富51購01 086409 1.33 -- -- 0.07000.00%0.00%0.00%0.00%448.50.11 價平 11.594% 0 31
愛普兆豐51購01 086613 2.02 -- -- 1.94000.00%0.00%0.00%0.00%299.990.02 價平 -32.171% 0 32
愛普群益51購03 086625 1.5 ▼-0.11 -6.83% 0.111.4700.00%0.00%0.00%12.36%4460.11 價平 11.099% 0 32
愛普元大51購02 086765 1.14 ▼-0.11 -8.8% 1.171.2120.00%70.33%71.57%0.03%445.50.08 價外 10.999% 0 32
愛普國泰52購01 086861 3.13 -- -- 3.09000.00%0.00%0.00%0.00%3200.036 價平 -23.906% 0 66
愛普元大51購03 087112 2.5 -- -- 2.452.500.00%56.35%71.01%0.02%3000.025 價內 -32.167% 0 34
愛普凱基51購02 087178 2.25 ▼-0.23 -9.27% 2.332.3800.00%0.00%0.00%0.02%3900.08 價平 -1.667% 0 35
愛普元大51購04 087402 3.27 ▲0.07 +2.19% 3.093.15830.00%69.88%72.06%0.02%367.50.062 價內 -7.891% 0 38
愛普凱基51購03 087634 3.97 -- -- 3.843.9400.00%0.00%0.00%0.03%3500.07 價平 -13.286% 0 39
愛普凱基51購04 087671 1.74 ▼-0.16 -8.42% 1.761.800.00%0.00%0.00%0.02%4500.12 價平 11.889% 0 40
愛普統一63購01 087692 0.86 -- -- 0.840.8500.00%0.00%0.00%0.01%451.680.006 價平 12.217% 0 465
愛普永豐51購02 087718 2.39 -- -- 0000.00%0.00%0.00%0.00%3250.028 價平 -22% 0 40
愛普永豐52購02 087719 2.55 ▼-0.09 -3.41% 0.88000.00%0.00%0.00%0.00%4000.058 價平 0.875% 0 80
愛普元富51購02 087756 2.74 -- -- 2.592.6300.00%0.00%0.00%0.02%4000.079 價平 0.875% 0 40
愛普群益51購04 087815 3.88 -- -- 3.613.7100.00%0.00%0.00%0.03%3350.05 價平 -18.358% 0 40
愛普元大51購05 087855 3.62 -- -- 3.533.6200.00%69.22%74.78%0.03%331.50.047 價內 -19.608% 0 40
愛普元大51購06 087856 4.02 -- -- 4.014.100.00%59.75%69.80%0.02%306.50.043 價內 -29.364% 0 40
愛普凱基51購05 087895 0.7 -- -- 0.740.7600.00%0.00%0.00%0.03%4860.13 價平 18.416% 0 41
〈愛普法說〉愛普*Q2受業外干擾每股虧3.36元 下半年營收估大增Anue鉅亨-2025/08/05
愛普* 相關文章